Addus HomeCare Q1 2026 Earnings Call Insights
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 05 2026
0mins
Should l Buy ADUS?
Source: seekingalpha
- Revenue Growth: Addus HomeCare reported total revenue of $363.6 million for Q1 2026, a 7.7% increase from $337.7 million in Q1 2025, indicating sustained growth potential in the personal care services sector despite a $1.5 million revenue loss due to weather impacts.
- Earnings Per Share Increase: The adjusted earnings per share rose to $1.62, up 14.1% from $1.42 in Q1 2025, reflecting improvements in cost control and operational efficiency, which may enhance investor confidence moving forward.
- Significant Cash Flow Improvement: The company generated $52.4 million in operating cash flow for Q1, a substantial increase from $18.9 million in the same period last year, indicating positive progress in financial health and capital management to support future acquisition plans.
- Strategic Acquisition Moves: Addus has completed the acquisition of HomeCourt's personal care operations in Indiana and plans to finalize another acquisition later this year, further solidifying its position in new markets and expected to drive future revenue growth.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ADUS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ADUS
Wall Street analysts forecast ADUS stock price to rise
5 Analyst Rating
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 92.410
Low
120.00
Averages
135.25
High
147.00
Current: 92.410
Low
120.00
Averages
135.25
High
147.00
About ADUS
Addus HomeCare Corporation is engaged in providing home care services. Its segments include Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. The services it provides include assistance with bathing, grooming, feeding and dressing, medication reminders and others. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and related services for their families. The Hospice services it provides include palliative nursing care, social work, spiritual counseling, homemaker services and bereavement counseling. Its Home Health segment provides services that are medical in nature to individuals who may require assistance during an illness or after hospitalization and includes skilled nursing and physical, occupational and speech therapy.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Revenue Growth: Addus HomeCare reported total revenue of $363.6 million for Q1 2026, a 7.7% increase from $337.7 million in Q1 2025, indicating sustained growth potential in the personal care services sector despite a $1.5 million revenue loss due to weather impacts.
- Earnings Per Share Increase: The adjusted earnings per share rose to $1.62, up 14.1% from $1.42 in Q1 2025, reflecting improvements in cost control and operational efficiency, which may enhance investor confidence moving forward.
- Significant Cash Flow Improvement: The company generated $52.4 million in operating cash flow for Q1, a substantial increase from $18.9 million in the same period last year, indicating positive progress in financial health and capital management to support future acquisition plans.
- Strategic Acquisition Moves: Addus has completed the acquisition of HomeCourt's personal care operations in Indiana and plans to finalize another acquisition later this year, further solidifying its position in new markets and expected to drive future revenue growth.
See More
- Investor Conference Schedule: Addus HomeCare will participate in the BofA Securities 2026 Health Care Conference in Las Vegas on May 12, 2026, where CEO Dirk Allison and CFO Brian Poff will present at 4:40 p.m. Pacific Time, potentially attracting significant investor interest.
- Global Healthcare Conference: Following this, Addus will attend the RBC Capital Markets 2026 Global Healthcare Conference in New York on May 19, 2026, with presentations by CEO Dirk Allison and CFO Brian Poff at 8:00 a.m. Eastern Time, further enhancing the company's visibility among investors.
- Live Broadcast and Replay: During the conferences, Addus will offer live broadcasts and replays, accessible through the Investor Relations section of its website, with replays available for one month starting one hour after the live event, ensuring broad dissemination of information.
- Service Coverage and Clientele: Currently, Addus HomeCare provides services to approximately 62,750 patients across 263 locations in 24 states, primarily serving elderly and chronically ill individuals at risk of hospitalization, highlighting the company's extensive impact in the home care market.
See More
- Conference Participation: Addus HomeCare will participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 16, 2026, with CEO Dirk Allison and CFO Brian Poff presenting virtually at 9:20 a.m. ET, showcasing the company's expertise in home care services.
- Second Conference: Following this, Addus HomeCare will attend the KeyBanc Capital Markets Healthcare Forum on March 17, 2026, where the same executives will present virtually at 11:15 a.m. ET, further enhancing the company's visibility among investors.
- Live Broadcast and Replay: The company will provide a live broadcast and replay of the presentations on its website under the Investor Relations section, with replays available approximately one hour after the live event, improving accessibility for investors unable to attend in real-time.
- Service Coverage: Addus HomeCare currently serves approximately 62,500 patients across 262 locations in 23 states, primarily assisting the elderly and chronically ill individuals, demonstrating the company's significant impact in the home care market.
See More
- Significant Revenue Growth: Addus HomeCare reported total revenue of $373.1 million for Q4 2025, reflecting a 25.6% year-over-year increase, with adjusted earnings per share at $1.77, up 28.3%, indicating strong performance and growth potential in the home care market.
- Ongoing Acquisition Strategy: Management emphasized the continued evaluation of acquisition opportunities that align with their strategy of geographic density and scale, with expectations for larger personal care assets to enter the market, further enhancing the company's market position.
- Impact of Rate Increases: Rate increases in Texas and Illinois are set to take effect on September 1, 2025, and January 1, 2026, respectively, which are expected to positively impact future results, particularly in Q1 2026.
- Strong Operational Performance: Despite facing seasonal and regulatory uncertainties, Addus demonstrated robust operational performance, with expectations for improved G&A cost leverage in 2026, further driving profitability enhancements.
See More
- ETF Decline: The iShares U.S. Healthcare Providers ETF fell approximately 1.9% in Tuesday afternoon trading, indicating a lack of confidence in the healthcare sector that could influence investor asset allocation decisions.
- Weak Individual Stocks: Within the ETF, Claritev's shares plummeted about 43.8%, while Addus Homecare dropped approximately 10.1%, raising concerns among investors regarding their future profitability and market positioning.
- Market Reaction Analysis: The overall weakness in the healthcare sector may reflect market uncertainty regarding policy changes or economic outlook, prompting investors to closely monitor relevant policy developments to assess future investment risks.
- Investor Sentiment Shift: The poor performance of the healthcare ETF may lead investors to reassess their investment strategies in the healthcare sector, potentially impacting capital inflows and market dynamics within the industry.
See More








